BNR
$18.55
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States.
Intraday
Recent News
Brenntag Q4 Earnings Call Highlights
Brenntag (ETR:BNR) executives said fiscal 2025 played out against one of the most prolonged downturns in the chemical industry in decades, with market conditions deteriorating as the year progressed and volumes weakening notably in the second half. On the company’s full-year results call, management
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs
Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price appreciation. BNR has surged 405% over the past year, hitting a 2-year high on Wednesday. Despite strong technicals, BNR is a highly speculative and risky stock. Today’s Chart of the Day is...
3 Promising Penny Stocks With Market Caps Over $40M
The U.S. stock market has been navigating a period of volatility, with major indices such as the Dow Jones Industrial Average and the S&P 500 experiencing fluctuations amid geopolitical tensions and economic policy discussions. Despite these broader market challenges, penny stocks remain an intriguing area for investors, representing smaller or newer companies that can offer potential value when backed by strong financials. In this context, we explore three penny stocks that exhibit financial...